4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
6.31
+0.53 (9.17%)
At close: Dec 20, 2024, 4:00 PM
6.62
+0.31 (4.91%)
After-hours: Dec 20, 2024, 4:16 PM EST
4D Molecular Therapeutics Stock Forecast
FDMT's stock price has decreased by -68.75% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 10 analysts with 12-month price forecasts for FDMT stock have an average target of 42.8, with a low estimate of 8.00 and a high estimate of 81. The average target predicts an increase of 578.29% from the current stock price of 6.31.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for FDMT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $79 → $46 | Strong Buy | Maintains | $79 → $46 | +629.00% | Dec 18, 2024 |
| Morgan Stanley | Morgan Stanley | Sell Initiates $8 | Sell | Initiates | $8 | +26.78% | Nov 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +518.07% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +470.52% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $39 | Buy | Maintains | $40 → $39 | +518.07% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
4.37M
from 20.72M
Decreased by -78.91%
Revenue Next Year
8.20M
from 4.37M
Increased by 87.55%
EPS This Year
-2.98
from -2.58
EPS Next Year
-3.50
from -2.98
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 22.1M | 22.1M | 18.9M | |||
| Avg | 4.4M | 8.2M | 6.9M | |||
| Low | 39,200 | n/a | 1.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 6.4% | 404.6% | 130.6% | |||
| Avg | -78.9% | 87.6% | -16.3% | |||
| Low | -99.8% | - | -77.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.64 | -0.96 | -2.89 | |||
| Avg | -2.98 | -3.50 | -3.97 | |||
| Low | -3.21 | -4.31 | -5.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.